Analyst Downgrades – Edge Therapeutics (NASDAQ:EDGE) (NASDAQ:EDGE) Stock Gets Downgraded By JMP Securities from Outperform to Market Perform

ME Staff
-
0

Analyst Ratings For Edge Therapeutics (NASDAQ:EDGE) (NASDAQ:EDGE)

Today, Edge Therapeutics (NASDAQ:EDGE) (NASDAQ:EDGE) stock was downgraded by JMP Securities from Outperform to Market Perform.

Some recent analyst ratings include

  • 3/28/2018-JMP Securities was Downgraded by analysts at JMP Securities from a “Outperform ” rating to a ” Market Perform” rating.
  • 1/18/2018-Credit Suisse Group Reiterated Rating of Outperform .
  • 3/3/2017-Leerink Swann Reiterated Rating of Outperform .
  • 3/3/2017-Guggenheim Reiterated Rating of Buy .

Recent Insider Trading Activity For Edge Therapeutics (NASDAQ:EDGE) (NASDAQ:EDGE)
Edge Therapeutics (NASDAQ:EDGE) (NASDAQ:EDGE) has insider ownership of 36.19% and institutional ownership of 48.89%.

  • On 3/21/2018 R. Loch Macdonald, Insider, sold 2,500 with an average share price of $16.52 per share and the total transaction amounting to $41,300.00.
  • On 3/19/2018 R. Loch Macdonald, Insider, sold 2,500 with an average share price of $16.66 per share and the total transaction amounting to $41,650.00.
  • On 3/1/2018 Brian A Leuthner, CEO, sold 2,500 with an average share price of $14.81 per share and the total transaction amounting to $37,025.00.
  • On 2/22/2018 R. Loch Macdonald, Insider, sold 2,500 with an average share price of $14.49 per share and the total transaction amounting to $36,225.00.
  • On 2/20/2018 R. Loch Macdonald, Insider, sold 5,000 with an average share price of $13.75 per share and the total transaction amounting to $68,750.00.
  • On 2/1/2018 Brian A Leuthner, CEO, sold 2,500 with an average share price of $13.14 per share and the total transaction amounting to $32,850.00.
  • On 1/3/2018 Brian A Leuthner, Insider, sold 5,000 with an average share price of $10.11 per share and the total transaction amounting to $50,550.00.

Recent Trading Activity for Edge Therapeutics (NASDAQ:EDGE) (NASDAQ:EDGE)
Shares of Edge Therapeutics (NASDAQ:EDGE) closed the previous trading session at 1.27 down -14.32 91.85% with shares trading hands.